Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Hamblin

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Leukemia Research|September 4, 2009
The TCL1 mouse as a model for chronic lymphocytic leukemiaTerry J Hamblin
Leukemia Research|May 15, 2002
UK CLL Forum, London, 25th October 2001Terry J Hamblin
Leukemia Research|September 26, 2006
Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiencyTerry J Hamblin
Leukemia & Lymphoma|June 20, 2007
ZAP-70 levels do change in CLL but not very oftenTerry J Hamblin
Leukemia Research|July 28, 2009
Just exactly how common is CLL?Terry J Hamblin
Leukemia Research|August 23, 2005
The management of anemia in the myelodysplastic syndromeTerry J Hamblin
Leukemia Research|August 26, 2006
Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?A Victor Hoffbrand, Terry J Hamblin
Expert Opinion on Therapeutic Targets|November 23, 2005
Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaAngela D Hamblin, Terry J Hamblin
British Journal of Haematology|December 7, 2007
Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia - long-term follow up of patients with different percentages of mutationsTerry J Hamblin, Zadie A Davis, David G Oscier
Leukemia Research|October 26, 2010
The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundationJohn M Bennett, Terry J Hamblin, Ghulam J Mufti
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Leukemia Research|September 4, 2009
The TCL1 mouse as a model for chronic lymphocytic leukemiaTerry J Hamblin
Leukemia Research|May 15, 2002
UK CLL Forum, London, 25th October 2001Terry J Hamblin
Leukemia Research|September 26, 2006
Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiencyTerry J Hamblin
Leukemia & Lymphoma|June 20, 2007
ZAP-70 levels do change in CLL but not very oftenTerry J Hamblin
Leukemia Research|July 28, 2009
Just exactly how common is CLL?Terry J Hamblin
Leukemia Research|August 23, 2005
The management of anemia in the myelodysplastic syndromeTerry J Hamblin
Leukemia Research|August 26, 2006
Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?A Victor Hoffbrand, Terry J Hamblin
Expert Opinion on Therapeutic Targets|November 23, 2005
Functional and prognostic role of ZAP-70 in chronic lymphocytic leukaemiaAngela D Hamblin, Terry J Hamblin
British Journal of Haematology|December 7, 2007
Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia - long-term follow up of patients with different percentages of mutationsTerry J Hamblin, Zadie A Davis, David G Oscier
Leukemia Research|October 26, 2010
The Myelodysplastic Syndromes (MDS) Foundation: a retrospective analysis of a nonprofit foundationJohn M Bennett, Terry J Hamblin, Ghulam J Mufti
Pageof 4